Effect of A. Lanata leaf extract and vediuppu chunnam on the urinary risk factors of calcium oxalate urolithiasis during experimental hyperoxaluria

Pharmacological Research

Volumn 43, Issue 1, 2001, Pages 89-93

  Selvam, R ^a   Kalaiselvi, P ^a   Govindaraj, A ^a   Bala Murugan, V ^a   Sathish Kumar, A S ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Aerva lanata; Calcium oxalate supersaturation; Hyperoxaluria; Urinary risk factors; Vediuppu chunnam

Indexed keywords

AERVA LANATA EXTRACT; ANTIUROLITHIASIS AGENT; CALCIUM; CALCIUM OXALATE; MAGNESIUM; OXALIC ACID; PHOSPHORUS; UNCLASSIFIED DRUG; URIC ACID; VEDIUPPU CHUNNAM;

AERVA LANATA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM OXALATE STONE; CONTROLLED STUDY; DRUG EFFICACY; HYPEROXALURIA; MALE; NONHUMAN; PLANT LEAF; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RAT; RISK FACTOR; URINARY EXCRETION; URINE VOLUME; UROLITHIASIS;

EID: 0034977991     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.2000.0745     Document Type: Article

References (30)

1. Effect of extra corporeal shock wave lithotripsy (ESWL) on renal tissue
2. Proximate composition, mineral content and fatty acids of cat fish (Ictalurus punctatus rafinesque) for different seasons and cooking methods
3. The colorimetric determination of phosphorus
4. Uric acid
5. Protein measurement using Folin-Ciocalteau reagent
6. An improved colorimetric procedure for urine oxalate
7. Antiurolithiatic and diuretic activity of lupeol
8. Effect of lupeol, a pentacyclic triterpene on urinary enzyme in hyperoxaluric rats
9. Effect of depletion of reduced glutathione and its supplementation by glutathione monoester on renal oxalate retention in hyperoxaluria
10. Vitamin E pretreatment prevents cyclosporin A-induced crystal deposition in hyperoxaluric rats
11. Solution chemistry of supersaturation
12. Evaluation of urine composition and calcium salt crystallization properties in standardized volume-adjusted 12-h night urine from normal subjects and calcium oxalate stone formers
13. Repeated urine analysis in patients with calcium stone disease
14. Role of citrate as an inhibitor of calcium oxalate stone formation in experimental urolithiasis
15. Hypercalciuria and stones
16. Effects of magnesium deficiency on intratubular calcium oxalate formation and crystalluria in hyperoxaluric rats
17. Animal models of kidney stone formation: An analysis
18. Inhibitors of calcium oxalate crystallisation in urine from stone formers and normals
19. Effect of C nurvala in experimental urolithiasis
20. Inhibitory effect of pyrophosphate, citrate, magnesium and chondriotin sulfate in calcium oxalate urolithiasis
21. The effect of urine pyrophosphate, citrate, magnesium and glycosaminoglycans on the growth and aggregation of calcium oxalate crystals in vitro
22. Randomized trial of allopurinol in the prevention of calcium oxalate in vitro
23. Alterations in some risk factors and urinary enzymes in urolithiatic rats treated with sodium pentosan polysulfate
24. Uric acid nephrolithiasis
25. Urate and calcium oxalate stones: From repute to rheotoric to reality
26. Dissolved urate promotes calcium oxalate crystallisation: Epitaxy is not the cause
27. Uric acid binding proteins in calcium oxalate crystallization
28. Evidence for the presence of abnormal proteins in the urine of recurrent stone formers
29. Urine composition in normal subjects after oral ingestion of oxalate rich foods